|
The Deshpande Center awarded three new grants in
its Fall 2005 round to teams whose work could result in new commercial
applications ranging from gas masks that neutralize nerve agents
to laboratory-grown human liver cells that test new drugs to a
new material enabling flexible computer displays.
The Center also awarded follow-on Innovation Grants to research
teams already exploring ways to commercialize two additional technologies — a
medical imaging process designed to pinpoint tiny cancer tumors,
and a multispectral infrared array technology that could result
in very-low-cost night-vision systems for military and security
applications. See our full
release for details.
back to top
"The past twenty years has seen technology advancement primarily
in new industries while large established industries have adopted
technology at a much slower rate. As a result, large industries
such as food, textiles, building materials, chemicals, plastics,
coatings, packaging, and many more, are ripe for innovation and
investment."
That's the idea behind an upcoming
forum, sponsored by Atlas Venture, called Innovating Established
Industries: Building Large New Businesses in New England. An Innovation
Showcase will feature four Deshpande Center projects that aim to
disrupt established industries: Novel
ice cream production method, Accelerating
innovation in the chemistry lab, Short-warp
weaving for fast-changing fashions, and A
cheaper, greener way to produce titanium.
The event,
which
is free with registration,
will bring together industry leaders, entrepreneurs, technologists,
investors, academics, and public sector professionals to share
information toward the goal of creating large new businesses that
fall outside the typical "venture backed startup" industries
of communications, enterprise software, and biotech. Go to Atlas
Venture's
web
site for more information about this event.
back to top

Left
to right: Institute Prof. Robert Langer, Helen Nugent, and Prof.
Elazer Edelman co-founded Pervasis
Therapeutics with Jay Vacanti in spring 2004.
Since awarding its first grants three years ago, the Deshpande
Center is already showing that a little bit of help early in the
innovation cycle goes a long way toward successful commercialization
of academic and scientific research. Cambridge biotechnology startup
Pervasis Therapeutics' recent announcement that it secured
$12 million in additional funding from top-tier venture capital
firms was a major milestone for both the company and the Center.
"The Deshpande Center was critical to the creation of Pervasis.
Deshpande associates and leadership
provide insightful guidance, and the Center's events present unique
contacts with an informed and enabling community," said Elazer
Edelman, a professor in the Harvard-MIT Division of Health Sciences
and Technology who
co-founded Pervasis.
Like Pervasis, more than a third of the 44 teams that have won
Deshpande Center grants are in the process of forming new companies,
raising venture capital, or seeking licensing arrangements with
established companies for their innovations. The group has raised
more than $36 million in private equity so far to develop and
deliver products based on their research. Collectively, they
are setting
a pattern for faster and more efficient commercialization of
academic research. See our full
release for details. back to top
 |
Institute Professor
Robert S. Langer (left) and MIT Provost L. Rafael Reif. |
MIT Provost L. Rafael Reif and MIT Institute Professor Robert
S. Langer have joined the Deshpande Center's Steering Committee,
rounding out a leadership group that includes outstanding individuals
from the upper reaches of both academia and industry. Reif, an
internationally recognized researcher and educator in microelectronics,
and Langer, who has over 500 issued or pending patents worldwide,
will help guide the Center as it expands its presence within MIT
and the broader business community.
"Provost Reif and Professor Langer have unique vision, knowledge,
and experience, not only with pure scientific discovery, but
also with the hands-on process of bringing practical innovations to
life. They will make a huge contribution to the Deshpande Center
as it fulfills its mission to help MIT innovators make a societal,
academic and economic impact," said Charles Cooney, faculty
director of the Deshpande Center and professor of Chemical and
Biochemical Engineering at MIT. See our full
release for details.
back to top
Deshpande Center grant winners have received media attention recently
for their work.
In a special section called Fortune 75: How the World Will Work,
Fortune magazine named Angela Belcher, professor of Biological
Engineering and Materials Science and Engineering, one of "ten
people to watch" for her work "investigating how nature
grows things and then trying to replicate the process in the lab."
BBC News profiled Chemical Engineering Professor Paula Hammond's
work in "smart" polymer coatings that deliver drugs
precisely where and when they are needed in the body.
Materials Science and Engineering Professor Francesco Stellacci
made the TR35 – Technology Review's list of the top
technology innovators under age 35 – thanks to his method
of producing DNA microarrays faster.
For links to these articles, go to our Press
page.
back to top
|